Rocket Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
RCKT
CUSIP
77313F106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 77313F106 since 12/18/2024, largest first.

Filer % of Class Filed
Vanguard Portfolio Management LLC 13G 5.4% 7/31/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Maverick Capital, Ltd. 13G/A
2.3% 2/13/2026
Event 12/31/2025
Wellington Management Group LLP 13G/A
0.9% 6/5/2025
Event 5/30/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 3.64 k $9.56 k
2026 Q2 187 99.8 M $342 M
2026 Q1 207 97.2 M $348 M
2025 Q4 193 91.3 M $323 M
2025 Q3 183 98.7 M $322 M
2025 Q2 211 97.6 M $239 M
2025 Q1 252 108 M $723 M
2024 Q4 239 110 M $1.38 B
2024 Q3 208 93.3 M $1.72 B
2024 Q2 195 92.7 M $1.99 B
2024 Q1 206 94.4 M $2.54 B
2023 Q4 218 91.0 M $2.73 B
2023 Q3 195 89.4 M $1.83 B
2023 Q2 172 77.6 M $1.54 B
2023 Q1 173 79.4 M $1.36 B
2022 Q4 181 80.4 M $1.57 B
2022 Q3 172 69.1 M $1.10 B
2022 Q2 152 64.8 M $892 M
2022 Q1 155 64.7 M $1.04 B
2021 Q4 154 65.7 M $1.43 B
2021 Q3 152 62.0 M $1.85 B
2021 Q2 163 64.7 M $2.86 B
2021 Q1 184 64.9 M $2.88 B
2020 Q4 189 62.6 M $3.43 B
2020 Q3 130 55.3 M $1.26 B
2020 Q2 124 54.5 M $1.14 B
2020 Q1 114 53.6 M $747 M
2019 Q4 127 52.4 M $1.19 B
2019 Q3 98 47.9 M $557 M
2019 Q2 110 49.5 M $743 M
2019 Q1 90 43.2 M $757 M
2018 Q4 92 42.5 M $627 M
2018 Q3 90 36.9 M $909 M
2018 Q2 78 34.1 M $665 M
2018 Q1 59 30.9 M $558 M